Development of a Natural Language Processing Tool to Enable Clinical Research in Emergency Medicine
Launched by MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH · Jan 26, 2024
Trial Information
Current as of July 27, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new tool that uses advanced computer technology, specifically a language model, to help researchers better understand information from emergency department medical records. The goal is to see if this tool can accurately read and extract important details from patient records of adults who visited the emergency department over a three-year period. By doing this, researchers hope to improve how they analyze and predict outcomes in emergency medicine.
To be eligible for this study, you need to be an adult who visited the emergency department between January 1, 2021, and December 31, 2023. There are no specific exclusions, meaning anyone who meets the age requirement and has received care in that time frame can participate. If you join, your medical information will be reviewed automatically by this language model, which means there will be no extra visits or procedures required from you. This research could lead to better ways to use patient data for future medical studies and improve emergency care for everyone.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adult
- • Arrived at emergency department between 1 January 2021 and 31 December 2023
- Exclusion Criteria:
- • None
About Mario Negri Institute For Pharmacological Research
The Mario Negri Institute for Pharmacological Research is a leading Italian biomedical research organization dedicated to advancing pharmacological science and improving public health. Established in 1963, the Institute focuses on innovative research methodologies, drug development, and clinical trials aimed at understanding and treating various diseases. With a multidisciplinary team of scientists and clinicians, the Institute collaborates with national and international partners to translate research findings into clinical applications, contributing significantly to the fields of pharmacology, epidemiology, and biostatistics. Committed to excellence in research and ethical standards, the Mario Negri Institute plays a vital role in shaping the future of medical science and enhancing therapeutic strategies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Vercelli, , Italy
Torino, , Italy
Milano, , Italy
Milano, , Italy
Orbassano, , Italy
Milan, , Italy
Catania, , Italy
Pozzuoli, , Italy
Patients applied
Trial Officials
Guido Bertolini
Principal Investigator
Istituto Di Ricerche Farmacologiche Mario Negri
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported